Home » Healthcare » Pharmaceuticals » Equine Healthcare Market

Equine Healthcare Market By Product (Vaccines, Pharmaceuticals – Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics, Other Pharmaceuticals; Medicinal Feed Additives; Orthobiologics; Diagnostics – Diagnostic Test Kits, Diagnostic Equipment; Software – Practice Management Software, Imaging Software, Telehealth Software, Other Software; Other Products); By Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis (EVA), Equine Influenza, West Nile Virus, Tetanus, Other Indications); By Activity (Sports or Racing, Recreation, Other Activities); By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Equine Healthcare Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-07-08
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Equine Healthcare Market

Summary
Table Of Content
Request Sample

Market Overview

The Equine Healthcare Market size was valued at USD 2,750.00 million in 2018, increased to USD 3,656.04 million in 2024, and is anticipated to reach USD 6,909.37 million by 2032, growing at a CAGR of 8.31% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Equine Healthcare Market Size 2024	USD 3,656.04 million
Equine Healthcare Market, CAGR	8.31%
Equine Healthcare Market Size 2032	USD 6,909.37 million

The Equine Healthcare market is led by prominent players such as Zoetis, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco, IDEXX Laboratories, Inc., Dechra Pharmaceuticals, Ceva Sante Animale, Heska Corporation, Arthrex Inc., Esaote SPA, Covetrus Inc., and Cargill. These companies focus on expanding their product portfolios, advancing diagnostic technologies, and investing in preventive care solutions to strengthen their market position. North America dominates the global equine healthcare market, holding a substantial 39.8% market share in 2024, driven by the region’s robust veterinary infrastructure, high equine sports participation, and increasing adoption of advanced healthcare technologies.

Market Insights

The Equine Healthcare market was valued at USD 2,750.00 million in 2018, reached USD 3,656.04 million in 2024, and is projected to hit USD 6,909.37 million by 2032, growing at a CAGR of 8.31% during the forecast period.
The market is driven by the rising prevalence of equine diseases such as musculoskeletal disorders and parasitic infections, along with the growing demand for advanced diagnostics and preventive healthcare solutions.
Increasing adoption of telehealth software, diagnostic test kits, and orthobiologic treatments are key trends transforming the equine healthcare landscape, particularly among sport and racing horses.
North America holds the largest regional share at 39.8% in 2024, followed by Europe at 24.3% and Asia Pacific at 22.5%; the pharmaceuticals segment remains the leading product category.
High treatment costs, limited veterinary access in rural areas, and regulatory complexities may restrain market expansion, particularly in developing regions.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Segmentation Analysis:

By Product

In the Equine Healthcare market, the pharmaceuticals segment holds the largest market share, driven by the growing prevalence of parasitic infections and musculoskeletal disorders among horses. Within pharmaceuticals, parasiticides dominate due to their critical role in preventing and managing parasitic infestations that significantly affect equine health and performance. Additionally, the rising demand for anti-infectives and anti-inflammatory drugs supports the segment’s growth. The diagnostics segment, particularly diagnostic test kits, is also witnessing steady expansion owing to increased emphasis on early disease detection. Advancements in telehealth software further contribute to improving equine health monitoring and remote consultations.

For instance, Zoetis’ QUEST PLUS Gel, a widely used equine dewormer, has been proven effective against 51 species and stages of equine parasites, enhancing parasite control protocols globally. Additionally, IDEXX Laboratories’ RealPCR testing platform processes over 2 million equine diagnostic tests annually, significantly contributing to faster and more accurate disease detection.

By Indication

Musculoskeletal disorders represent the dominant sub-segment in the equine healthcare market by indication, accounting for the largest revenue share. This dominance is primarily attributed to the high incidence of joint, tendon, and ligament injuries among sport and racing horses, which require continuous medical attention and preventive care. Additionally, parasitic infections hold a substantial share, driven by the need for regular deworming and parasite control. The growing awareness about equine viral diseases, such as equine herpes virus and equine influenza, further drives the demand for vaccines and diagnostic solutions, supporting the overall growth across multiple indications.

For instance, Boehringer Ingelheim’s Legend (hyaluronate sodium) has been used in over 5 million joint treatments worldwide, offering effective management of equine joint diseases. Additionally, Merck Animal Health’s EQUINN vaccine provides protection against equine influenza and has been administered to thousands of horses globally, ensuring preventive care in competitive and recreational segments.

By Activity

The sports/racing segment leads the equine healthcare market by activity, holding the largest market share due to the significant healthcare investments required to maintain the performance and well-being of competitive horses. These horses frequently experience injuries and stress-related conditions, driving consistent demand for pharmaceuticals, diagnostics, and orthobiologic treatments. The recreation segment is also expanding, supported by increasing pet ownership and leisure horse-riding activities. However, sports and racing remain the primary drivers of advanced healthcare services and products in the market, as the economic and competitive stakes in this activity necessitate rigorous and ongoing veterinary care.

Market Overview

Rising Incidence of Equine Diseases

The increasing prevalence of equine diseases such as musculoskeletal disorders, parasitic infections, and viral conditions is a major driver for the equine healthcare market. These health issues demand continuous veterinary attention, regular vaccinations, and diagnostic testing to ensure the well-being of horses, especially those involved in racing and sports activities. The need for timely disease management and preventive care is driving the consumption of pharmaceuticals, vaccines, and diagnostic products, thereby accelerating market growth across both developed and emerging regions.

For instance, Boehringer Ingelheim has distributed over 1.5 million doses of its Vetera vaccines annually to protect horses against equine influenza and West Nile Virus.

Growth in Equine Sports and Recreational Activities

The expansion of equine sports, racing events, and recreational horse-riding activities globally is significantly boosting the demand for advanced healthcare solutions. Competitive horses require rigorous health monitoring, injury management, and routine medical care to maintain peak performance. Rising investments by horse owners and equestrian facilities in preventive healthcare, rehabilitation, and performance enhancement are supporting the growth of pharmaceuticals, orthobiologics, and diagnostic services. This trend is especially prominent in regions with well-established equestrian industries such as North America and Europe.

For instance, Arthrex Inc. has developed advanced regenerative therapies, including the Arthrex ACP (Autologous Conditioned Plasma) system, which has treated over 100,000 equine musculoskeletal injuries worldwide.

Increasing Adoption of Advanced Veterinary Technologies

Technological advancements in veterinary diagnostics, telehealth software, and practice management solutions are transforming equine healthcare. The availability of portable diagnostic equipment and telemedicine platforms enables timely consultations, accurate disease detection, and improved treatment outcomes. These innovations support better disease management, especially in remote areas with limited access to veterinary clinics. The integration of digital solutions into equine healthcare practices enhances operational efficiency and expands the accessibility of specialized care, further propelling market growth.

Key Trends & Opportunities

Growing Demand for Preventive Healthcare

There is a notable shift towards preventive healthcare among horse owners and veterinary professionals, aiming to reduce long-term treatment costs and improve animal welfare. Regular vaccination programs, routine diagnostics, and parasite control measures are gaining traction, creating opportunities for pharmaceutical companies and diagnostic kit manufacturers. This proactive approach is expected to generate sustained demand for high-quality vaccines, anti-parasitic drugs, and preventive diagnostic services across key markets.

For instance, Covetrus Inc. supports preventive care programs through its equine wellness plans, servicing over 500,000 horses annually through its integrated veterinary network and digital platforms.

Expansion of E-commerce and Online Veterinary Services

The rising penetration of e-commerce platforms and the growth of online veterinary services present significant opportunities in the equine healthcare market. Horse owners increasingly prefer the convenience of purchasing pharmaceuticals, supplements, and diagnostic kits through digital channels. Additionally, telehealth platforms enable virtual consultations, remote diagnostics, and faster treatment initiation. This shift not only improves product accessibility but also allows veterinary service providers to expand their customer reach, particularly in underserved regions.

For instance, Chewy’s online veterinary pharmacy has processed over 20,000 equine prescription orders monthly, offering direct-to-doorstep services across the United States. Moreover, Zoetis’ Vetscan Imagyst platform, which supports AI-based fecal diagnostics, has been deployed in over 1,500 veterinary clinics globally, with more than 250,000 fecal samples processed through the system since its launch, enhancing rapid and remote diagnostic capabilities.

Key Challenges

High Cost of Equine Healthcare

One of the primary challenges in the equine healthcare market is the high cost associated with veterinary treatments, advanced diagnostics, and specialty pharmaceuticals. Expenses related to surgeries, orthobiologic therapies, and regular medical care can be prohibitive for many horse owners, especially in recreational segments. This financial burden may limit access to timely and comprehensive healthcare services, thereby restraining market growth in certain regions.

Limited Access in Rural and Remote Areas

Access to quality equine healthcare services remains a critical issue in rural and remote regions. Many horse owners in these areas face challenges in obtaining timely veterinary care, diagnostic testing, and pharmaceuticals due to a lack of specialized facilities and professionals. This limited access can lead to delayed treatments and increased disease prevalence, posing a significant barrier to market expansion and effective healthcare delivery.

Regulatory and Product Approval Complexities

Stringent regulatory frameworks governing animal health products, including vaccines and pharmaceuticals, can delay the introduction of new therapies in the equine healthcare market. Compliance with diverse national and international standards adds to the complexity and cost of product development. These regulatory hurdles often result in prolonged approval timelines and may restrict smaller companies from entering the market, thereby limiting product availability and innovation.

Regional Analysis

North America

North America dominates the Equine Healthcare market, holding the largest market share of approximately 39.8% in 2024. The market was valued at USD 1,107.15 million in 2018 and is projected to reach USD 2,747.87 million by 2032, growing at a robust CAGR of 8.3%. This growth is primarily driven by the high prevalence of equine sports and racing, substantial investments in veterinary healthcare, and the widespread adoption of advanced diagnostic and treatment technologies. The region’s well-established veterinary infrastructure and increasing awareness about preventive equine care further contribute to North America’s market leadership.

Europe

Europe accounts for a significant 24.3% market share in 2024, with its equine healthcare market valued at USD 695.75 million in 2018 and expected to reach USD 1,580.54 million by 2032, growing at a CAGR of 7.5%. The market is driven by a strong equestrian culture, government support for animal welfare, and a growing emphasis on equine disease management. Increased spending on recreational and competitive horse activities further supports market growth. The rising demand for diagnostic solutions and pharmaceuticals is enhancing the regional market’s competitiveness, with countries like Germany, France, and the UK leading this expansion.

Asia Pacific

Asia Pacific is emerging as the fastest-growing region in the Equine Healthcare market, holding a 22.5% market share in 2024. The market was valued at USD 588.50 million in 2018 and is anticipated to reach USD 1,744.52 million by 2032, registering a CAGR of 9.9%. Rapid economic growth, increasing horse ownership, and expanding recreational equestrian activities across China, India, and Australia are key growth drivers. Additionally, improving access to veterinary care and growing awareness of preventive healthcare measures are strengthening market potential. The region’s dynamic growth presents significant opportunities for healthcare providers and veterinary pharmaceutical companies.

Latin America

Latin America holds a 7.1% market share in 2024 in the Equine Healthcare market. The market size stood at USD 195.80 million in 2018 and is expected to reach USD 456.50 million by 2032, growing at a CAGR of 7.4%. The market is primarily supported by the growing popularity of equestrian sports and recreational activities, especially in countries like Brazil and Argentina. Increasing awareness of animal health, coupled with gradual improvements in veterinary infrastructure, is positively impacting market growth. However, limited access to advanced equine treatments in rural areas continues to present a challenge for the regional market.

Middle East

The Middle East represents a 4.2% market share in 2024 in the Equine Healthcare market. The regional market was valued at USD 94.88 million in 2018 and is projected to reach USD 197.65 million by 2032, expanding at a CAGR of 6.8%. The region’s market growth is primarily driven by the high cultural and economic value placed on horses, particularly in Gulf countries where equestrian sports such as endurance racing are prominent. Increasing investment in veterinary services and infrastructure, along with a growing focus on preventive care and specialized pharmaceuticals, is supporting steady market expansion in the Middle East.

Africa

Africa holds the smallest share of the Equine Healthcare market with 3.1% in 2024. The market was valued at USD 67.93 million in 2018 and is expected to grow to USD 182.30 million by 2032, at a CAGR of 5.5%. The region’s growth is driven by increasing awareness of equine disease management and a gradual improvement in veterinary care access. However, limited availability of advanced healthcare facilities and pharmaceuticals continues to constrain market growth. Despite these challenges, the growing equestrian communities in countries such as South Africa are expected to contribute to the steady development of the equine healthcare sector.

Market Segmentations:

By Product

Vaccines
Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory & Analgesics
- Other Pharmaceuticals
Medicinal Feed Additives
Orthobiologics
Diagnostics
- Diagnostic Test Kits
- Diagnostic Equipment
Software
- Practice Management Software
- Imaging Software
- Telehealth Software
- Other Software
Other Products

By Indication

Musculoskeletal Disorders
Parasitic Infections
Equine Herpes Virus
Equine Viral Arteritis (EVA)
Equine Influenza
West Nile Virus
Tetanus
Other Indications

By Activity

Sports/Racing
Recreation
Other Activities

By Distribution Channel

Veterinary Hospitals & Clinics
E-commerce
Equestrian Facilities
Others

By Geography:

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Competitive Landscape

The equine healthcare market is highly competitive, with several key players focusing on expanding their product portfolios and strengthening their global presence. Leading companies such as Zoetis, Boehringer Ingelheim, Merck & Co., and Elanco dominate the market, offering a wide range of pharmaceuticals, vaccines, and diagnostic solutions tailored for equine care. These players actively engage in strategic partnerships, acquisitions, and product innovations to maintain their market leadership. Companies like IDEXX Laboratories and Heska Corporation focus on advancing diagnostic technologies, while Arthrex and Ceva Sante Animale emphasize orthopedic and therapeutic solutions. The market also witnesses growing competition from emerging players leveraging e-commerce platforms and telehealth services to improve product accessibility. Continuous investment in research and development, particularly in preventive care and digital veterinary solutions, remains a key competitive strategy across the industry. The presence of both multinational corporations and specialized veterinary companies creates a dynamic and evolving competitive landscape within the equine healthcare sector.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Zoetis
Arthrex Inc.
Dechra Pharmaceuticals
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Heska Corporation
Merck & Co. Inc
Esaote SPA
IDEXX Laboratories, Inc.
Covetrus Inc.
Elanco
Cargill

Recent Developments

In May 2025, Zoetis announced the opening of its largest U.S. diagnostics reference laboratory in Louisville, Kentucky. This state-of-the-art facility is designed to deliver faster, more precise, and more accessible diagnostic testing for veterinarians, including services relevant to equine health. The lab will be fully operational by the end of 2025, enhancing Zoetis’ capacity for cytology, chemistry, hematology, microbiology, and more.

In July 2024, San Giovanni Battista Hospital of Rome announced that their equine-assisted therapy program helped in improving motor skills in over 600 neurology patients.
In June 2024, Hartpury University along with AnimalWeb launched a new research study aimed at mapping the biosecurity practices in the equine industry of UK. This study will help in shaping equine health-related policies in the country.
In June 2024, Merck Animal Health and US Trotting Association announced installation milestone of over 50,000 Bio-Thermo microchips in race horses. These microchips assist the horse owners in accurately and remotely monitoring health parameters like temperature and also help in recordkeeping.
In May 2024, Curative Sounds launched a novel product for companion and equine patients, Extracorporeal Shockwave Therapy (ESWT) device. This is considered world’s first portable ESWT device and is applicable in treating musculoskeletal disorders.
In May 2024, Mixlab acquired NexGen Animal Health. This acquisition was done by Mixlab to expand their existing pharmacy services beyond companion animals and into large animals like horse and cattle.

Market Concentration & Characteristics

The Equine Healthcare Market is moderately concentrated, with a mix of global leaders and regional players actively competing to strengthen their market presence. It demonstrates strong product diversity, covering pharmaceuticals, vaccines, diagnostics, and software solutions tailored for equine care. Leading companies focus on expanding their portfolios and introducing advanced diagnostic technologies to meet the evolving healthcare needs of sport, racing, and recreational horses. The market shows high entry barriers due to strict regulatory frameworks, extensive product approval processes, and significant investment requirements in research and development. North America holds the largest share, supported by established veterinary infrastructure and a well-developed equine sports industry. The market benefits from growing awareness of preventive healthcare and increasing demand for specialized equine treatments. It relies heavily on veterinary hospitals, clinics, and e-commerce platforms to ensure product accessibility. While the market presents growth opportunities through innovation and expanding telehealth solutions, high treatment costs and limited veterinary access in rural areas continue to challenge its full potential.

Report Coverage

The research report offers an in-depth analysis based on Product, Indication, Activity, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The equine healthcare market is expected to experience steady growth driven by increasing investments in equine sports and recreational activities.
Demand for advanced pharmaceuticals and orthobiologic treatments will continue to rise as owners prioritize the health and performance of their horses.
The adoption of telehealth software and remote diagnostic technologies is likely to accelerate, improving accessibility to veterinary care.
Preventive healthcare practices such as regular vaccinations, parasite control, and routine diagnostics will gain wider acceptance among horse owners.
The pharmaceutical segment, particularly parasiticides and anti-infectives, is projected to maintain its dominance due to their essential role in equine care.
North America will remain the leading region, supported by strong veterinary infrastructure and high equine healthcare spending.
The Asia Pacific region is expected to emerge as the fastest-growing market, driven by increasing horse ownership and expanding equestrian activities.
E-commerce platforms will play a growing role in the distribution of equine healthcare products, improving accessibility and convenience.
Rising awareness about equine viral diseases will boost the demand for effective vaccines and diagnostic solutions.
High treatment costs and limited access to specialized care in rural areas may continue to challenge the market’s growth potential.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : EQUINE HEALTHCARE MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by product

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Indication Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product & Indication Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Equine Healthcare Market Import Revenue By Region

6.2. Export Analysis by Region

6.2.1. Global Equine Healthcare Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Equine Healthcare Market: Company Market Share

7.2. Global Equine Healthcare Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : EQUINE HEALTHCARE MARKET – BY PRODUCT SEGMENT ANALYSIS

8.1. Equine Healthcare Market Overview by Product Segment

8.1.1. Equine Healthcare Market Revenue Share By Product

8.2. Vaccines

8.3. Pharmaceuticals

8.3.1 Parasiticides

8.3.2 Anti-infectives

8.3.3 Anti-inflammatory & Analgesics

8.3.4 Other Pharmaceuticals

8.4. Medicinal Feed Additives

8.5. Ortho biologics

8.6. Diagnostics

8.6.1 Diagnostic Test Kits

8.6.2 Diagnostic Equipment

8.7. Software

8.7.1 Practice Management Software

8.7.2 Imaging Software

8.7.3 Telehealth Software

8.7.4 Other Software

8.8. Other Products

CHAPTER NO. 9 : EQUINE HEALTHCARE MARKET – BY INDICATION SEGMENT ANALYSIS

9.1. Equine Healthcare Market Overview by Indication Segment

9.1.1. Equine Healthcare Market Revenue Share By Indication

9.2. Musculoskeletal Disorders

9.3. Parasitic Infections

9.4. Equine Herpes Virus

9.5. Equine Viral Arteritis (EVA)

9.6. Equine Influenza

9.7. West Nile Virus

9.8. Tetanus

9.9. Other Indications

CHAPTER NO. 10 : EQUINE HEALTHCARE MARKET – BY ACTIVITY SEGMENT ANALYSIS

10.1. Equine Healthcare Market Overview by Activity Segment

10.1.1. Equine Healthcare Market Revenue Share By Activity

10.2. Sports/Racing

10.3. Recreation

10.4. Other Activities

CHAPTER NO. 11 : EQUINE HEALTHCARE MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS

11.1. Equine Healthcare Market Overview by Distribution Channel Segment

11.1.1. Equine Healthcare Market Revenue Share By Distribution Channel

11.2. Veterinary Hospitals & Clinics

11.3. E-commerce

11.4. Equestrian Facilities

11.5. Others

CHAPTER NO. 12 : EQUINE HEALTHCARE MARKET – REGIONAL ANALYSIS

12.1. Equine Healthcare Market Overview by Region Segment

12.1.1. Global Equine Healthcare Market Revenue Share By Region

12.1.2. Regions

12.1.3. Global Equine Healthcare Market Revenue By Region

12.1.4. Product

12.1.5. Global Equine Healthcare Market Revenue By Product

12.1.6. Indication

12.1.7. Global Equine Healthcare Market Revenue By Indication

12.1.8. Activity

12.1.9. Global Equine Healthcare Market Revenue By Activity

12.1.10. Distribution Channel

12.1.11. Global Equine Healthcare Market Revenue By Distribution Channel

CHAPTER NO. 13 : NORTH AMERICA EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

13.1. North America Equine Healthcare Market Overview by Country Segment

13.1.1. North America Equine Healthcare Market Revenue Share By Region

13.2. North America

13.2.1. North America Equine Healthcare Market Revenue By Country

13.2.2. Product

13.2.3. North America Equine Healthcare Market Revenue By Product

13.2.4. Indication

13.2.5. North America Equine Healthcare Market Revenue By Indication

13.2.6. Activity

13.2.7. North America Equine Healthcare Market Revenue By Activity

13.2.8. Distribution Channel

13.2.9. North America Equine Healthcare Market Revenue By Distribution Channel

13.3. U.S.

13.4. Canada

13.5. Mexico

CHAPTER NO. 14 : EUROPE EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

14.1. Europe Equine Healthcare Market Overview by Country Segment

14.1.1. Europe Equine Healthcare Market Revenue Share By Region

14.2. Europe

14.2.1. Europe Equine Healthcare Market Revenue By Country

14.2.2. Product

14.2.3. Europe Equine Healthcare Market Revenue By Product

14.2.4. Indication

14.2.5. Europe Equine Healthcare Market Revenue By Indication

14.2.6. Activity

14.2.7. Europe Equine Healthcare Market Revenue By Activity

14.2.8. Distribution Channel

14.2.9. Europe Equine Healthcare Market Revenue By Distribution Channel

14.3. UK

14.4. France

14.5. Germany

14.6. Italy

14.7. Spain

14.8. Russia

14.9. Rest of Europe

CHAPTER NO. 15 : ASIA PACIFIC EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

15.1. Asia Pacific Equine Healthcare Market Overview by Country Segment

15.1.1. Asia Pacific Equine Healthcare Market Revenue Share By Region

15.2. Asia Pacific

15.2.1. Asia Pacific Equine Healthcare Market Revenue By Country

15.2.2. Product

15.2.3. Asia Pacific Equine Healthcare Market Revenue By Product

15.2.4. Indication

15.2.5. Asia Pacific Equine Healthcare Market Revenue By Indication

15.2.6. Activity

15.2.7. Asia Pacific Equine Healthcare Market Revenue By Activity

15.2.8. Distribution Channel

15.2.9. Asia Pacific Equine Healthcare Market Revenue By Distribution Channel

15.3. China

15.4. Japan

15.5. South Korea

15.6. India

15.7. Australia

15.8. Southeast Asia

15.9. Rest of Asia Pacific

CHAPTER NO. 16 : LATIN AMERICA EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

16.1. Latin America Equine Healthcare Market Overview by Country Segment

16.1.1. Latin America Equine Healthcare Market Revenue Share By Region

16.2. Latin America

16.2.1. Latin America Equine Healthcare Market Revenue By Country

16.2.2. Product

16.2.3. Latin America Equine Healthcare Market Revenue By Product

16.2.4. Indication

16.2.5. Latin America Equine Healthcare Market Revenue By Indication

16.2.6. Activity

16.2.7. Latin America Equine Healthcare Market Revenue By Activity

16.2.8. Distribution Channel

16.2.9. Latin America Equine Healthcare Market Revenue By Distribution Channel

16.3. Brazil

16.4. Argentina

16.5. Rest of Latin America

CHAPTER NO. 17 : MIDDLE EAST EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

17.1. Middle East Equine Healthcare Market Overview by Country Segment

17.1.1. Middle East Equine Healthcare Market Revenue Share By Region

17.2. Middle East

17.2.1. Middle East Equine Healthcare Market Revenue By Country

17.2.2. Product

17.2.3. Middle East Equine Healthcare Market Revenue By Product

17.2.4. Indication

17.2.5. Middle East Equine Healthcare Market Revenue By Indication

17.2.6. Activity

17.2.7. Middle East Equine Healthcare Market Revenue By Activity

17.2.8. Distribution Channel

17.2.9. Middle East Equine Healthcare Market Revenue By Distribution Channel

17.3. GCC Countries

17.4. Israel

17.5. Turkey

17.6. Rest of Middle East

CHAPTER NO. 18 : AFRICA EQUINE HEALTHCARE MARKET – COUNTRY ANALYSIS

18.1. Africa Equine Healthcare Market Overview by Country Segment

18.1.1. Africa Equine Healthcare Market Revenue Share By Region

18.2. Africa

18.2.1. Africa Equine Healthcare Market Revenue By Country

18.2.2. Product

18.2.3. Africa Equine Healthcare Market Revenue By Product

18.2.4. Indication

18.2.5. Africa Equine Healthcare Market Revenue By Indication

18.2.6. Activity

18.2.7. Africa Equine Healthcare Market Revenue By Activity

18.2.8. Distribution Channel

18.2.9. Africa Equine Healthcare Market Revenue By Distribution Channel

18.3. South Africa

18.4. Egypt

18.5. Rest of Africa

CHAPTER NO. 19 : COMPANY PROFILES

19.1. Zoetis

19.1.1. Company Overview

19.1.2. Product Portfolio

19.1.3. Financial Overview

19.1.4. Recent Developments

19.1.5. Growth Strategy

19.1.6. SWOT Analysis

19.2. Arthrex Inc.

19.3. Dechra Pharmaceuticals

19.4. Boehringer Ingelheim International GmbH

19.5. Ceva Sante Animale

19.6. Heska Corporation

19.7. Merck & Co. Inc

19.8. Esaote SPA

19.9. IDEXX Laboratories, Inc.

19.10. Covetrus Inc.

19.11. Elanco

19.12. Cargill

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Question:

What is the current size of the Equine Healthcare Market?

The Equine Healthcare Market is valued at USD 3,656.04 million in 2024.

What factors are driving the growth of the Equine Healthcare Market?

The market is driven by rising equine disease prevalence, growing equine sports activities, and increasing adoption of advanced diagnostics.

What are some challenges faced by the Equine Healthcare Market?

High treatment costs, limited veterinary access in rural areas, and complex regulatory approvals are major challenges.

are the major players in the Equine Healthcare Market?

Major players include Zoetis, Boehringer Ingelheim, Merck & Co., Elanco, IDEXX Laboratories, and Dechra Pharmaceuticals.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Equine Veterinary Therapeutics Market

The Equine Veterinary Therapeutics Market is projected to grow from USD 1,393.7 million in 2024 to USD 2,448.87 million by 2032, at a compound annual growth rate (CAGR) of 7.3%.

Farrier Products Market

The Farrier Products Market was valued at USD 428.7 million in 2024 and is projected to reach USD 657.9 million by 2032, growing at a CAGR of 5.5% during the forecast period.

Companion Animal Health Market

The Companion Animal Health Market size was valued at USD 16,480.00 million in 2018 to USD 21,533.66 million in 2024 and is anticipated to reach USD 41,198.66 million by 2032, at a CAGR of 8.51% during the forecast period.

UK Animal Bedding Market

The UK Animal Bedding Market size was valued at USD 40.25 million in 2018 to USD 53.79 million in 2024 and is anticipated to reach USD 77.66 million by 2032, at a CAGR of 4.37% during the forecast period.

Horse Bunk Feeder Market

The Global Horse Bunk Feeder Market is projected to grow from USD 1,682 million in 2024 to an estimated USD 2,218 million by 2032, reflecting a compound annual growth rate (CAGR) of 3.52% from 2025 to 2032.

Horse Sickness Treatment Market

The global Horse Sickness Treatment Market is projected to grow from USD 1,381.2 million in 2024 to USD 2,373.15 million by 2032, at a compound annual growth rate (CAGR) of 7% during the forecast period.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample